Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Good Morning Everyone,
View:
Post by valentinemasson on Sep 08, 2020 11:14am

Good Morning Everyone,

The news of RS seems to be causing divisive lines in the proverbial sand. Many here have amassed 10`s of thousands of shares , as have a few big players, albeit in the millions of shares as we have seen in the past months.

 The timing and unpredictability of the RS , many , including myself thought sp should be in the neighbourhood of at least performing the RS to hold $4 US to apply to Nasdaq. The timing is a take charge attitude , according to news releases and interviews ,  Aristotle quite likely has already been presented to clinics , hospital networks , utilizing sz`s new partnerships  pointing to an inroads given by SZ  performing their clients` tests to FDA regulations, stressing the lab to maximum capacity, creating an atmosphere that is robust with activity and a new normal , and accuracy leading up to Aristotle`s release.

 
 The 1/2 penny fluctuation is frustrating and James made it clear he wanted to intervene by performing a reverse split paring down the share count to deter from manipulation. So, it should come as no surprise , the reverse split is occurring much sooner than we expected. After the split, important to remember the entities that have amassed millions of shares and there are a few, may attempt to encourage a sell off to gain more shares from shaky investors . After the split, there will be less than 50 million shares . In comparison, SONA has their own test as SZ does, and has 60 million shares, That went from 1 penny in December 2019 to $16 recently. To those saying SZ will be brought back down to 8 or 9 cents have no interests in the saving of lives with Covid testing and Aristotle . Other interests at play. A market cap of $4 million makes no sense, SZ is projected to have earned upper single digits in USD Millions by EOY, this low cap IMO will not happen. The responsible thing for SZ to do, is exactly whjat they are doing. To those that voted in favor of the split knew the timing could be unpredictable , it certainly has the attention of many. Bravo James.

 All of the above, is in my opinion only and not verbatim. Vets, chime in here .

 Holding ,

 Good luck All.

 VM.
Comment by Bucky86 on Sep 08, 2020 11:54am
Really well said VM. I feel like it's a bit of a chicken or egg thing though. I feel like they could accomplish some of the same things with tjbgod Q3 results but ultimately a RS is need as many have pointed out. I would have liked to see it happen at the same time of a good news release and build momentum.....something this company has failed to do on its own
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities